App-Quantinova.ai

When Can Patients Be Safely Discharged After Alcohol Septal Ablation? Incidence and Timing of Post-Ablation Complete Heart Block and Ventricular Tachycardia

Bassim El-Sabawi - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Simultaneous Interventional Treatment of Patients With Hypertrophic Obstructive Cardiomyopathy and Coexisting Coronary Artery Disease

Stanislav Fanta - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Changes in Quality of Life in Patients With Low-Flow Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Aisha Ahmed - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Impact of Diastolic Dysfunction on Mortality and Quality of Life After Transcatheter Aortic Valve Replacement

Mahesh Anantha Narayanan - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Left Ventricular Cardiac Reshaping With Trans-Myocardial Splints Does Not Impair Diastolic Function in Preclinical Studies

Daisuke Onohara - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Reducing Left Ventricular Sphericity With a Trans-Ventricular Myocardial Splint Improves Systolic Function in a Preclinical Ischemic Cardiomyopathy Model

Daisuke Onohara - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Transfemoral Transcatheter Aortic Valve Replacement Using Fascia Iliaca Block as an Alternative Approach to Conscious Sedation as Compare to General Anesthesia: Findings From a Single Center

Wei Lau - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Incidence and Prognostic Significance of Heart Failure Hospitalization After Transcatheter or Surgical Aortic Valve Replacement: Results From the PARTNER Trials

Chetan Huded - Transcatheter Cardiovascular Therapeutics (TCT) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Safety and Effectiveness of Transcatheter Edge-to-Edge Repair With MitraClip in Atrial Functional MR: An Analysis of the Global EXPAND Study

Nishtha Sodhi - Transcatheter Cardiovascular Therapeutics (TCT) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Short- and Long-Term Performance of Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy

Ahmad Mahmoud - Transcatheter Cardiovascular Therapeutics (TCT) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Initial Clinical Experience With a No-Implant Interatrial Shunt for Heart Failure

Peter Fail - Transcatheter Cardiovascular Therapeutics (TCT) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Change in Left Ventricular Diastolic Dysfunction After Transcatheter Aortic Valve Replacement and Outcomes in Patients With Severe Aortic Stenosis

Ali Malik - Transcatheter Cardiovascular Therapeutics (TCT) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Coronary Microvascular Dysfunction in Takotsubo Cardiomyopathy Assessed by Angiography-Derived Index of Microcirculatory Resistance, a Pressure Wire–Free Tool

Estefanía Fernández Peregrina - Transcatheter Cardiovascular Therapeutics (TCT) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Impact of Chronic Obstructive Pulmonary Disease on Quality-of-Life Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

Nicole Hoover - Transcatheter Cardiovascular Therapeutics (TCT) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Heart muscle disease

N/A

Endovascular Baroreflex Therapy for Heart Failure With Reduced Ejection Fraction: First-in-Human Results

Horst Sievert - Transcatheter Cardiovascular Therapeutics (TCT) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Greater Splanchnic Nerve Ablation in Chronic Heart Failure: Preserved Versus Reduced Left Ventricular Ejection Fraction

Vivek Reddy - Transcatheter Cardiovascular Therapeutics (TCT) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

An 8-year-old child with ROHAAD syndrome and its comorbid association with narcolepsy, cardiomyopathy, and malignant catatonia

Meghana Pattipati - Associated Professional Sleep Societies (SLEEP) , 2023

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

N/A

New insight of itch mediators and proinflammatory cytokines in epidermolysis bullosa

H. Nguyen - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Heart muscle disease

Interferon Gamma

Molecular characterization of trametinib-induced cardiotoxicity

T.C. Beck - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

Doxorubicin

Aldose Reductase Inhibition by AT-001 Limits Diastolic Dysfunction and Adverse Remodelling in Diabetic Cardiomyopathy

QUTUBA G. KARWI - American Diabetes Association (ADA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

Streptozotocin

Filters

3340 Abstracts